These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29085520)

  • 1. Erratum: Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
    Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
    Oncol Lett; 2017 Oct; 14(4):5051. PubMed ID: 29085520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
    Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
    Oncol Lett; 2017 Jul; 14(1):776-786. PubMed ID: 28693233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating KL-6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome.
    Nakashima T; Yokoyama A; Ohnishi H; Hamada H; Ishikawa N; Haruta Y; Hattori N; Tanigawa K; Kohno N
    J Intern Med; 2008 Apr; 263(4):432-9. PubMed ID: 18298483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
    Ishikawa N; Hattori N; Yokoyama A; Kohno N
    Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia.
    Zhu Y; Fu J; You K; Jin L; Wang M; Lu D; Xue X
    Exp Lung Res; 2013 Dec; 39(10):417-26. PubMed ID: 24298937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells.
    Endo S; Nishimura N; Kawano Y; Ueno N; Ueno S; Tatetsu H; Komohara Y; Takeya M; Hata H; Mitsuya H; Masao M; Okuno Y
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):246-252. PubMed ID: 30420285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
    Seko A; Ohkura T; Ideo H; Yamashita K
    Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
    Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma.
    Inata J; Hattori N; Yokoyama A; Ohshimo S; Doi M; Ishikawa N; Hamada H; Kohno N
    Int J Cancer; 2007 Jun; 120(12):2643-9. PubMed ID: 17294451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers.
    Inagaki Y; Xu H; Nakata M; Seyama Y; Hasegawa K; Sugawara Y; Tang W; Kokudo N
    Biosci Trends; 2009 Dec; 3(6):220-32. PubMed ID: 20103851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum].
    Onco Targets Ther; 2019; 12():9115. PubMed ID: 31806996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method.
    Zhao Y; Zhao S; Chen Y; Dong X; Peng C; Sun Q; Shan L; Wang Z; Zhao X
    Oncol Lett; 2019 Nov; 18(5):5653. PubMed ID: 31666815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition.
    Xie W; Liu X; Chen Q; Ma M; Yang X; Gong B; Sun T; Chen J
    Oncol Lett; 2019 Jul; 18(1):967. PubMed ID: 31289576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels.
    Horimasu Y; Hattori N; Ishikawa N; Kawase S; Tanaka S; Yoshioka K; Yokoyama A; Kohno N; Bonella F; Guzman J; Ohshimo S; Costabel U
    Respir Med; 2012 Dec; 106(12):1756-64. PubMed ID: 22995277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.